Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $125,444 - $139,287
1,969 Added 15.9%
14,354 $917,000
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $721,627 - $818,488
-10,982 Reduced 47.0%
12,385 $858,000
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $1.21 Million - $1.43 Million
17,630 Added 307.3%
23,367 $1.68 Million
Q3 2022

Nov 15, 2022

SELL
$0.13 - $76.84 $237 - $140,617
-1,830 Reduced 24.18%
5,737 $408,000
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $364,189 - $401,099
-5,015 Reduced 39.86%
7,567 $583,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $29,325 - $35,164
477 Added 3.94%
12,582 $919,000
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $18,019 - $21,006
-336 Reduced 2.7%
12,105 $755,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $203,485 - $238,357
3,439 Added 38.2%
12,441 $736,000
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $37,207 - $40,519
-601 Reduced 6.26%
9,002 $601,000
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $17,386 - $19,554
-293 Reduced 2.96%
9,603 $606,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $1.72 Million - $1.95 Million
-29,742 Reduced 75.03%
9,896 $614,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $69,605 - $77,131
-1,212 Reduced 2.97%
39,638 $2.39 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $2.24 Million - $2.62 Million
40,850 New
40,850 $2.4 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $670,804 - $795,335
-15,684 Closed
0 $0
Q2 2019

Nov 12, 2019

BUY
$44.62 - $49.34 $699,820 - $773,848
15,684 New
15,684 $711,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $798,591 - $1.04 Million
-16,378 Closed
0 $0
Q3 2018

Feb 13, 2019

BUY
$55.19 - $62.25 $568,953 - $641,735
10,309 Added 169.86%
16,378 $1.02 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $135,824 - $169,290
2,688 Added 79.5%
6,069 $336,000
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $124,993 - $143,892
2,086 Added 161.08%
3,381 $172,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $77,622 - $84,628
1,295
1,295 $79,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.